The objective of the Wilmer ClinicianScientist Training Program (CSTP) is to foster the development of clinician-scientists through mentored training by our experienced research faculty. The Wilmer Institute has a well-developed program for clinician-scientist training that utilizes governmental grants, private philanthropy, faculty commitment to education, and core facilities throughout the Johns Hopkins School of Medicine and the Bloomberg School of Public Health. The Wilmer CSTP program uniquely merges clinical investigation into visual disorders with the methodologies of clinical trials, public health, epidemiology, outcomes assessment and the finest in laboratory investigation in molecular biology, molecular genetics, and gene therapy. To continue our successful program in the career development of clinicianscientists, we seek a continuation of a total of 3 positions under the K12 mechanism, enrolling each of the 3 candidates for training periods of up to 4 years.

Public Health Relevance

Our specific objective is to provide the training and mentorship that will lead each of these young persons to be successful as faculty members in Schools of Medicine and Public Health and to achieve funded, independent research programs.

National Institute of Health (NIH)
Physician Scientist Award (Program) (PSA) (K12)
Project #
Application #
Study Section
Special Emphasis Panel (ZEY1)
Program Officer
Agarwal, Neeraj
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
Schools of Medicine
United States
Zip Code
Ramulu, Pradeep Y; Chan, Emilie S; Loyd, Tara L et al. (2012) Comparison of home and away-from-home physical activity using accelerometers and cellular network-based tracking devices. J Phys Act Health 9:809-17
Boland, Michael V; Quigley, Harry A (2011) Evaluation of a combined index of optic nerve structure and function for glaucoma diagnosis. BMC Ophthalmol 11:6
Oveson, Brian C; Iwase, Takeshi; Hackett, Sean F et al. (2011) Constituents of bile, bilirubin and TUDCA, protect against oxidative stress-induced retinal degeneration. J Neurochem 116:144-53
Boland, Michael V; Quigley, Harry A; Lehmann, Harold P (2011) The impact of physician subspecialty training, risk calculation, and patient age on treatment recommendations in ocular hypertension. Am J Ophthalmol 152:638-645.e1
Quaia, Christian; Ying, Howard S; Optican, Lance M (2010) The viscoelastic properties of passive eye muscle in primates. III: force elicited by natural elongations. PLoS One 5:e9595
Boland, Michael V; Lehmann, Harold P (2010) A new method for determining physician decision thresholds using empiric, uncertain recommendations. BMC Med Inform Decis Mak 10:20
Danesh-Meyer, Helen V; Boland, Michael V; Savino, Peter J et al. (2010) Optic disc morphology in open-angle glaucoma compared with anterior ischemic optic neuropathies. Invest Ophthalmol Vis Sci 51:2003-10
Ramulu, Pradeep (2009) Glaucoma and disability: which tasks are affected, and at what stage of disease? Curr Opin Ophthalmol 20:92-8
Ramulu, Pradeep Y; West, Sheila K; Munoz, Beatriz et al. (2009) Driving cessation and driving limitation in glaucoma: the Salisbury Eye Evaluation Project. Ophthalmology 116:1846-53
Quaia, Christian; Ying, Howard S; Nichols, Altah M et al. (2009) The viscoelastic properties of passive eye muscle in primates. I: static forces and step responses. PLoS One 4:e4850

Showing the most recent 10 out of 26 publications